CYCC
Cyclacel Pharmaceuticals Inc
NASDAQ: CYCCP · HEALTHCARE · BIOTECHNOLOGY
$5.05
+0.00% today
Updated 2026-04-30
Market cap
$9.60M
P/E ratio
—
P/S ratio
960.24x
EPS (TTM)
$-2.05
Dividend yield
—
52W range
$3 – $9
Volume
—
Cyclacel Pharmaceuticals Inc (CYCCP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+7.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2021-06-30 | $0.00 | $-0.54 | — | — | — |
| 2021-03-31 | $0.00 | $-0.56 | — | — | — |
| 2020-12-31 | $0.00 | $-0.50 | — | — | — |
| 2020-09-30 | $0.00 | $-1.34 | — | — | — |
| 2020-06-30 | $-0.47 | $-0.58 | -23.4% | — | — |
| 2020-03-31 | $-2.90 | $-1.48 | +49.0% | — | — |
| 2019-12-31 | $-2.70 | $-2.80 | -3.7% | — | — |
| 2019-09-30 | $-3.13 | $-2.20 | +29.7% | — | — |
| 2019-06-30 | $-3.13 | $-2.20 | +29.7% | — | — |
| 2019-03-31 | $-4.10 | $-2.80 | +31.7% | — | — |
| 2018-12-31 | $-3.47 | $-3.40 | +2.0% | — | — |
| 2018-09-30 | $-3.40 | $-3.60 | -5.9% | — | — |
Frequently asked questions
Has Cyclacel Pharmaceuticals Inc beaten earnings estimates?
Cyclacel Pharmaceuticals Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports.